WondfoBiotech Co., Ltd(Wondfo) was founded in 1992as a research based company on the campus of South China Universityof Technology in Guangzhou, Guangdong Province. Theoperation quickly grew beyond research purposestowards custommanufacturing of quality medical products and biochemicalreagents. With strongsupport from the government and local university, Wondfo hasobtained ISO 9001certificate,GMP approval,FDA approval and CE Markalready.Currently Wondfoemploys over 400employees housed in state ofthe art facilities encompassingover 30,000square feet of laboratoryspace. Based on thetechnical resources from South China University of Technologyover 30% of theemployed staff have obtained master and doctordegree fromprestigious worldwide institutions. By consistently investingresources in staff training and technological development, Wondfois constantly building a superb team of professionals in qualitycontrol, production, management, and international distributionoperations. Wondfo has pioneered new and advanced engineering techniques inimmunological manufacturing by combining artistry of thedevelopment team with technological application of automatedmanufacturing equipment. In order to assure the product of bestquality and stability, Wondfo established the aseptic workshop(according to the GMP standards), in addition to temperature andhumidity controlled lab environment. Wondfo also houses a technicalteam that has developedcustomized ImmunogoldLabelingTechniques withautomated procedures for water purgation, cell cultivation, purityanalysis, packaging & sorting, andtesting.Wondfo pays  strict attention to quality control processes while  utilizing  cost  cutting application ofautomated equipment, resultingin superbquality products with veryaffordable prices. Wondfo alsofocuses on excellent client-centered support with experienced salesand marketing team that is fluent inboth Chinese andEnglish, in addition tostrong international import -export experience. Thefuture plans include product diversification with strong marketingexpansion into North andSouth America, Europe, Middle East, and other demandingmarkets. Wondfo iscurrently developing plans to obtain certificates forboth USFDA and EuropeanCE Mark registrationsfor all the products, in order to fulfill distributor needs inthose regions.Infection Markers: CRP, PCTâ Cardiac Markers: NT-proBNP, cTnI, Myo,CK-MB, H-FABP, 3 in 1â Coagulation Marker: D-Dmierâ Renal Injury Marker: MAUâ Diabetes Marker: HbA1câ Tumor Markers: AFP, FSAÂ